These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 2045154)

  • 1. Antihypertensive action of medullipin I given by mouth.
    Muirhead EE; Brooks B; Byers LW; Toba K; Share L
    Hypertension; 1991 Jun; 17(6 Pt 2):1092-6. PubMed ID: 2045154
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biologic differences between vasodilator prostaglandins and medullipin I.
    Muirhead EE; Brooks B; Byers LW
    Am J Med Sci; 1992 Feb; 303(2):86-9. PubMed ID: 1539615
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Secretion of medullipin I by isolated kidneys perfused under elevated pressure.
    Muirhead EE; Brooks B; Byers LW; Brown P; Pitcock JA
    Clin Exp Pharmacol Physiol; 1991 Jun; 18(6):409-17. PubMed ID: 1914243
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The renal antihypertensive endocrine function: its relation to cytochrome P-450.
    Muirhead EE; Byers LW; Capdevila J; Brooks B; Pitcock JA; Brown PS
    J Hypertens; 1989 May; 7(5):361-9. PubMed ID: 2504817
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Renal vasodepressor mechanisms: the medullipin system.
    Muirhead EE
    J Hypertens Suppl; 1993 Dec; 11(5):S53-8. PubMed ID: 8158434
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Is the humoral renal antihypertensive activity of the spontaneously hypertensive rat (SHR) reset to the high blood pressure?
    Karlström G; Bergström G; Folkow B; Rudenstam J; Göthberg G
    Acta Physiol Scand; 1991 Apr; 141(4):517-30. PubMed ID: 1877351
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Secretion of medullipin I by the kidney involves the cytochrome P-450 enzyme system.
    Muirhead EE; Brooks B; Byers LW
    J Hypertens; 1994 Feb; 12(2):155-8. PubMed ID: 8021466
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The medullipin system of blood pressure control.
    Muirhead EE
    Am J Hypertens; 1991 Oct; 4(10 Pt 2):556S-568S. PubMed ID: 1741992
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Derivation of antihypertensive neutral renomedullary lipid from renal venous effluent.
    Muirhead EE; Byers LW; Desiderio DM; Pitcock JA; Brooks B; Brown PS; Brosius WL
    J Lab Clin Med; 1982 Jan; 99(1):64-75. PubMed ID: 6798154
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Purification of class I medullipins from the venous effluent of isolated normal kidneys perfused under high pressure with saline.
    Brooks B; Byers LW; Muirhead EE; Muirhead M; Pitcock JA; Maddipati KR; Maxey KM
    Blood Press; 1994 Nov; 3(6):407-17. PubMed ID: 7704290
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Secretion of medullipin I by the kidney requires oxygen.
    Muirhead EE; Brooks B; Byers LW
    J Hypertens; 1992 Sep; 10(9):963-7. PubMed ID: 1328377
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The vasodepressor function of the kidney: further characterization of medullipin and a second hormone designated angiolysin.
    Glodny B; Pauli GF
    Hypertens Res; 2006 Jul; 29(7):533-44. PubMed ID: 17044666
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Medullipin system. Generation of medullipin II by isolated kidney-liver perfusion.
    Muirhead EE; Brooks B; Byers LW; Brown P; Pitcock JA
    Hypertension; 1991 Nov; 18(5 Suppl):III158-63. PubMed ID: 1937680
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of chronic ETA-selective endothelin receptor antagonism on blood pressure in experimental and genetic hypertension in rats.
    Schiffrin EL; Turgeon A; Deng LY
    Br J Pharmacol; 1997 Jul; 121(5):935-40. PubMed ID: 9222550
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacological studies of N-(2,5-dimethyl-1H-pyrrol-1-yl)-6-(4-morpholinyl)-3-pyridazinamine hydrochloride (MDL-899), a new long-acting antihypertensive vasodilator.
    Baldoli E; Bianchi G; Corsico N; Di Francesco GF
    Arzneimittelforschung; 1985; 35(5):818-26. PubMed ID: 2862874
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interaction between irbesartan, peroxisome proliferator-activated receptor (PPAR-γ), and adiponectin in the regulation of blood pressure and renal function in spontaneously hypertensive rats.
    Afzal S; Sattar MA; Johns EJ; Abdulla MH; Akhtar S; Hashmi F; Abdullah NA
    J Physiol Biochem; 2016 Dec; 72(4):593-604. PubMed ID: 27405250
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structural and functional adaptation in the rat myocardium and coronary vascular bed caused by changes in pressure and volume load.
    Friberg P
    Acta Physiol Scand Suppl; 1985; 540():1-47. PubMed ID: 3161269
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biologic contrasts between medullipin I and vasoactive glyceryl compounds.
    Muirhead EE; Byers LW; Brooks B; Brown P; Pitcock JA
    Am J Med Sci; 1989 Aug; 298(2):93-103. PubMed ID: 2764021
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cardiovascular pharmacology of nicardipine in animals.
    Takenaka T; Asano M; Shiono K; Shibasaki M; Inagaki O
    Br J Clin Pharmacol; 1985; 20 Suppl 1(Suppl 1):7S-22S. PubMed ID: 4027153
    [TBL] [Abstract][Full Text] [Related]  

  • 20. BQ-123, a selective endothelin subtype A-receptor antagonist, lowers blood pressure in different rat models of hypertension.
    Douglas SA; Gellai M; Ezekiel M; Ohlstein EH
    J Hypertens; 1994 May; 12(5):561-7. PubMed ID: 7930556
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.